Loading...

Cell Staining Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Staining Buffer, Washing Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Save
420201 500 mL ¥19,580
Description

Cell Staining Buffer is an antibody diluent and cell wash buffer optimized for use in immunofluorescent staining of viable or fixed single cell suspensions. Cell Staining Buffer contains bovine calf serum as a protein carrier to reduce non-specific binding of antibodies and fluorochrome reagents to target cells. It also contains a metabolic inhibitor, sodium azide (NaN3), to inhibit patching and capping of cell surface antigens. To prevent interference in biotin/avidin indirect staining protocols, Cell Staining Buffer is formulated without biotin, calcium, magnesium, and EDTA.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICC, ICFC - Reported in the literature, not verified in house
Application References

(PubMed link indicates BioLegend citation)
  1. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed.
  2. Yu DH, et al. 2013. Mol Cell Biol. 33:1845. PubMed.
  3. Garcia JA, et al. 2013. J Immunol. 191:1063. PubMed
  4. Lukas S, et al. 2013. J Biomol Screen. 19:407. PubMed
  5. Murali VK, et al. 2014. J. Virol. 88:903. PubMed
  6. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  7. de Vires M, 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  8. Della-Torre E, et al. 2014. Ann Rheum Dis. PubMed
  9. Dong A, et al. 2015. J Biol Chem. 290:8016. PubMed
Product Citations
  1. Zhao SM, et al. 2020. Biomed Res Int. 2020:1879640. PubMed
  2. Hall BM, et al. 2020. Aging Cell. 19:e13219. PubMed
  3. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  4. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  5. Chandler A, et al. 2022. J Orthop Res. 40:1918. PubMed
  6. Wang W, et al. 2022. Mol Cancer Res. 20:1137. PubMed
  7. Shcheynikov N, et al. 2022. Hepatology. 76:1248. PubMed
  8. Lyu J, et al. 2022. Mol Biol Cell. 33: . PubMed
  9. Sugimoto M, et al. 2022. DNA Res. 29: . PubMed
  10. Emmrich S, et al. 2022. EMBO J. 41:e109694. PubMed
  11. Shichino S, et al. 2022. Commun Biol. 5:602. PubMed
  12. Wang X, et al. 2022. Sci Adv. 8:eabn0071. PubMed
  13. Wang L, et al. 2022. Viruses. 14: . PubMed
  14. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  15. Stabel JR, et al. 2022. PLoS One. 17:e0278313. PubMed
  16. Church KA, et al. 2022. J Neuroinflammation. 19:300. PubMed
  17. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  18. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  19. Sun W, et al. 2023. Nature. 614:309. PubMed
  20. Chulpanova DS, et al. 2023. Curr Issues Mol Biol. 45:571. PubMed
  21. Li X, et al. 2023. J Transl Med. 21:121. PubMed
  22. Kerns JS, et al. 2023. Bio Protoc. 13: . PubMed
  23. Issa N, et al. 2023. Leukemia. :. PubMed
  24. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  25. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  26. Su CC, et al. 2022. Invest Ophthalmol Vis Sci. 63:18. PubMed
  27. Apfelbaum AA, et al. 2022. Clin Cancer Res. 28:4466. PubMed
  28. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  29. Brady SW, et al. 2022. Nat Genet. 54:1376. PubMed
  30. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  31. Udayasuryan B, et al. 2022. Sci Signal. 15:eabn4948. PubMed
  32. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  33. Zhong J, et al. 2022. J Adv Res. 41:145. PubMed
  34. Lam D, et al. 2023. Nat Biotechnol. 41:686. PubMed
  35. You S, et al. 2023. Sci Adv. 9:eade7923. PubMed
  36. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  37. Xu T, et al. 2023. JCI Insight. 8:. PubMed
  38. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  39. Lee J, et al. 2023. Front Cell Dev Biol. 11:1144110. PubMed
  40. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  41. Shi P, et al. 2023. Commun Biol. 6:334. PubMed
  42. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  43. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  44. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  45. Feng Y, et al. 2023. J Transl Med. 21:290. PubMed
  46. Quintela M, et al. 2023. Br J Cancer. . PubMed
  47. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  48. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  49. Tai W, et al. 2023. Nat Commun. 14:2962. PubMed
  50. Chen Z, et al. 2023. Nat Commun. 14:3469. PubMed
  51. Taylor J, et al. 2023. Front Immunol. 14:1119350. PubMed
  52. Wu L, et al. 2023. Cell Res. . PubMed
  53. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  54. Oreskovic E, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  55. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  56. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  57. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  58. Nuccitelli R, et al. 2017. J Immunother Cancer . 10.1186/s40425-017-0234-5. PubMed
  59. Djeungoue–Petga MA, et al. 2019. Cell Death Dis. 1.069444444. PubMed
  60. Markowicz-Piasecka M, et al. 2020. Apoptosis. 25:426. PubMed
  61. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  62. Lee HH, et al. 2021. Nat Commun. 12:2788. PubMed
  63. Su T, et al. 2021. Metabolites. 11:. PubMed
  64. Murthy S, et al. 2022. Cell Death Dis. 13:53. PubMed
  65. Yildirim Z, et al. 2022. EMBO Mol Med. 14:e15344. PubMed
  66. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  67. Kodani Y, et al. 2022. Front Endocrinol (Lausanne). 13:941166. PubMed
  68. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  69. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  70. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  71. Stewart AN, et al. 2021. J Neuroinflammation. 18:113. PubMed
  72. Gawriluk TR, et al. 2020. Front Immunol. 1.635416667. PubMed
  73. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  74. Lee H, et al. 2019. Cancer Res. 79:2839. PubMed
  75. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  76. Swaroop M, et al. 2018. Hum Mol Genet. 27:3612. PubMed
  77. Li Y, et al. 2021. Nat Commun. 12:87. PubMed
  78. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  79. Pino P, Cardona A 2011. J Vis Exp. 48: 2348. PubMed
  80. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  81. Mercatelli D, et al. 2021. Methods Protoc. 4: . PubMed
  82. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  83. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  84. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  85. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  86. Brito-Pérez Y, et al. 2021. Immun Inflamm Dis. 9:1541. PubMed
  87. Mei KC, et al. 2020. ACS Nano. 14:13343. PubMed
  88. Nam AR, et al. 2020. Cancer Res Treat. 52:945. PubMed
  89. Deng W, et al. 2017. J Immunol. 198(1):492-504. PubMed
  90. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  91. Garcia J, et al. 2013. J Immunol. 191:1063. PubMed
  92. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  93. Gilad Y, et al. 2019. Sci Rep. 9:15099. PubMed
  94. Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed
  95. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  96. Drummer DJ, et al. 2022. Int J Exerc Sci. 15:686. PubMed
  97. Liao C, et al. 2017. Endocr Relat Cancer. 10.1530/ERC-16-0138. PubMed
  98. Joachim R, Suber F, and Kobzik L 2017. Sci Rep. . 10.1038/s41598-017-16743-1. PubMed
  99. Luo G, et al. 2017. PLoS One. 12:e0187305. PubMed
  100. Moose DL, et al. 2020. Cell Rep. 30:3864. PubMed
  101. Soldi R, et al. 2020. PLoS One. 15:e0235705. PubMed
  102. Krivanek J, et al. 2020. Nat Commun. 3.802777778. PubMed
  103. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  104. Wurzer H, et al. 2021. Front Immunol. 12:619069. PubMed
  105. Yoshioka H, et al. 2021. Front Cell Dev Biol. 9:621045. PubMed
  106. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  107. Ogbe A, et al. 2022. JCI Insight. . PubMed
  108. Song S, et al. 2022. Front Immunol. 13:804306. PubMed
  109. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  110. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  111. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  112. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  113. Choreño-Parra JA, et al. 2021. J Immunol Res. 2021:5517856. PubMed
  114. Bodnar B, et al. 2021. Front Cell Neurosci. 15:682272. PubMed
  115. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  116. Wan J, et al. 2021. Front Pharmacol. 11:590723. PubMed
  117. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  118. Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  119. Yu D, et al. 2013. Mol Cell Biol. 33:1845. PubMed
  120. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  121. Hao Q, et al. 2022. Front Immunol. 13:1011922. PubMed
  122. Lee D, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  123. Feng S, et al. 2017. Cancer Sci. 108:12:00. PubMed
  124. Zhou L, et al. 2017. Tumour Biol. 39:1010428317694313. PubMed
  125. Wang D, et al. 2015. Gastroenterology. Available online 7 August 2015. PubMed
  126. Gorshkov K, et al. 2020. bioRxiv. . PubMed
  127. Huangfu J, et al. 2021. Cell Death Dis. 12:386. PubMed
  128. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  129. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  130. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  131. Xie L, et al. 2020. Front Oncol. 1.354166667. PubMed
  132. Watkins–Schulz R, et al. 2019. Biomaterials. 205:94. PubMed
  133. Ryans K, et al. 2017. BMC Immunology . 10.1186/s12865-017-0212-1. PubMed
  134. Li X, et al. 2022. Bone Res. 10:46. PubMed
  135. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  136. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  137. Teravskis PJ, et al. 2018. J Neurosci. 38:9754. PubMed
  138. Lukas S, et al. 2013. J Biomol Screen. 19:407. PubMed
  139. Jia C, et al. 2015. Fish Shellfish Immunol. 45: 300-306. PubMed
  140. Garg A, Trout R, Spector S 2017. Sci Rep. 10.1038/srep44485. PubMed
  141. Emmrich S, et al. 2021. Aging Cell. 20:e13477. PubMed
  142. Uprichard SL, et al. 2022. Viruses. 14:. PubMed
  143. Kodani Y, et al. 2022. Eneuro. 9:. PubMed
  144. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  145. Han Y, et al. 2021. Cell Death Dis. 12:993. PubMed
  146. Pang K, et al. 2022. Cell Death Dis. 13:169. PubMed
  147. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  148. McQueen BE, et al. 2020. Infect Immun. :88. PubMed
  149. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  150. Della-Torre E, et al. 2015. Ann Rheum Dis. 74: 2236 - 2243. PubMed
  151. Putz EJ, et al. 2019. J Dairy Sci. 102:9268. PubMed
  152. Wang Z, et al. 2020. Oncogenesis. 0.431944444. PubMed
  153. Crifò B, et al. 2019. J Immunol. 202:1521. PubMed
  154. La T, et al. 2018. Cancer Res. 78:6666. PubMed
  155. Liu X, et al. 2022. Cell Discov. 8:58. PubMed
  156. Matsumoto K, et al. 2017. PLoS One. 12(6):e0175406. PubMed
  157. Surdziel E, et al. 2017. PLoS One.. 10.1371/journal.pone.0183679. PubMed
  158. Li Y, et al. 2019. Mol Med Rep. 3.90625. PubMed
  159. Putz EJ, et al. 2020. BMC Vet Res. 0.9. PubMed
  160. Toutounchian J, et al. 2016. Mol Pharmacol. 91(1):1-13. PubMed
  161. Verma N, et al. 2020. Sci Adv. 6:00. PubMed
  162. Chen CZ, et al. 2020. ACS Pharmacol Transl Sci. 1165:3. PubMed
  163. Bartkowiak K, et al. 2021. Cancers (Basel). 13: . PubMed
  164. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  165. Hernandez-Davies JE, et al. 2022. Sci Rep. 12:9198. PubMed
  166. McQueen BE, et al. 2021. Infect Immun. 89:e0007221. PubMed
  167. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  168. Gupta Y, et al. 2021. Int J Biol Macromol. 183:203. PubMed
  169. Jordakieva G, et al. 2021. Oncoimmunology. 10:1880687. PubMed
  170. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  171. Becerril C, et al. 2021. Biomolecules. 11:. PubMed
  172. Ishida M, et al. 2021. Int J Mol Sci. 22:. PubMed
  173. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  174. Li Y, et al. 2021. Stem Cell Res Ther. 12:358. PubMed
  175. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  176. Mitry MA, et al. 2020. American Journal of Physiology-Cell Physiology. 318(2):C380-C391. PubMed
  177. Dai S, et al. 2017. Autophagy. 1.538194444. PubMed
  178. Ren C, et al. 2022. J Cell Mol Med. 26:1071. PubMed
  179. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  180. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  181. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
  182. Wang J, et al. 2019. Oncol Lett. 4.948611111. PubMed
  183. Yang WH, et al. 2018. Cancer Res. 78:3761. PubMed
  184. Thiele M, et al. 2015. J Immunol. 195: 2343-2352. PubMed
  185. Gorshkov K, et al. 2020. ACS Infect Dis. . PubMed
  186. Alasady MJ, et al. 2021. PLoS One. 16:e0256238. PubMed
  187. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  188. Hasanpourghadi M, et al. 2021. Curr Trends Microbiol. 15:1. PubMed
  189. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  190. Han MG, et al. 2022. Cancers (Basel). 14:. PubMed
  191. Dustin CM, et al. 2021. J Immunol. 206:2989. PubMed
  192. Xu M, et al. 2022. SLAS Discov. 27:86. PubMed
  193. Babaei A, et al. 2020. Daru. 28:555. PubMed
  194. Pearce AC, et al. 2021. J Biol Chem. 297:100928. PubMed
  195. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  196. Harro CM, et al. 2020. J Clin Invest. . PubMed
  197. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  198. Fries-Craft K, et al. 2020. PLoS One. 15:e0236106. PubMed
  199. Khoa LTP, et al. 2020. STAR Protoc. 1:100136. PubMed
  200. Motedayyen H, et al. 2017. BMC Res Notes. . 10.1186/s13104-017-2880-6. PubMed
  201. Aguisanda F, et al. 2017. Orphanet J Rare Dis. 10.1186/s13023-017-0670-9. PubMed
  202. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  203. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  204. King P, et al. 2021. Int J Oncol. 59:. PubMed
  205. Peng Z, et al. 2022. J Neuroinflammation. 19:186. PubMed
  206. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  207. Chen H, et al. 2022. Mol Ther Methods Clin Dev. 27:431. PubMed
  208. Tak YE, et al. 2017. Nat Methods. 14:1163. PubMed
  209. Li B, et al. 2018. Cancer Res. 78:3938. PubMed
  210. Ma H, et al. 2015. Sci Rep. 5: 15121. PubMed
  211. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  212. Gorshkov K, et al. 2020. J Pharmacol Exp Ther. 374:500. PubMed
  213. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  214. You C, et al. 2021. Cancers (Basel). 13:. PubMed
  215. Salameh JW, et al. 2022. Bioengineering (Basel). 9:. PubMed
  216. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  217. Ji Y, et al. 2021. Nanomaterials (Basel). 11: . PubMed
  218. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  219. Chen Q, et al. 2020. Aging (Albany NY). 12:3682. PubMed
  220. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  221. Li B, et al. 2021. Clin Cancer Res. 27:6543. PubMed
  222. Gao M, et al. 2022. BMC Mol Cell Biol. 23:32. PubMed
  223. Shi X, et al. 2017. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 10.1016/j.bbamcr.2017.05.012. PubMed
  224. Brocato ER, et al. 2018. PLoS One. 13:e0197701. PubMed
  225. Nozhat Z, et al. 2018. Daru. 26:93. PubMed
  226. Hsiao W, et al. 2015. PLoS One. 10: 0145880. PubMed
  227. Chen W, et al. 2016. Nat Commun. 7: 11302. PubMed
  228. Wang M, et al. 2016. Sci Rep. 6: 34060. PubMed
  229. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  230. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  231. Tao Z, et al. 2022. Cells. 11:. PubMed
  232. Fan L, et al. 2022. Theranostics. 12:6809. PubMed
  233. Saddawi-Konefka R, et al. 2022. Nat Commun. 13:4298. PubMed
  234. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  235. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  236. Seo HR, et al. 2021. Cancer Res Treat. Online ahead of print. PubMed
  237. Wang L, et al. 2021. Metabolites. 11:. PubMed
  238. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  239. Pogozhykh D, et al. 2017. Stem Cell Res Ther. 10.1186/s13287-017-0512-7. PubMed
  240. Mishra P, et al. 2016. PLoS Negl Trop Dis. 10: 0004787. PubMed
  241. Williams K, et al. 2015. J Neuroimmunol. 285: 76-93. PubMed
  242. Simic D, et al. 2019. Exp Hematol. 72:36. PubMed
  243. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  244. Bianchi A, et al. 2022. Genome Biol. 23:229. PubMed
  245. Dudley A, et al. 2017. American Journal of Veterinary Research. 10.2460/ajvr.78.5.589. PubMed
  246. Kawamura D, et al. 2017. Oncol Rep.. 10.3892/or.2017.5974. PubMed
  247. Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed
  248. Murali V, et al. 2014. J Virol. 88:903. PubMed
  249. Palma M, et al. 2017. Haematologica. 10.3324/haematol.2016.151100. PubMed
  250. Di Franco S, et al. 2021. STAR Protoc. 2:100880. PubMed
  251. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  252. Chen C, et al. 2022. iScience. 25:103645. PubMed
  253. Yang P, et al. 2022. Oxid Med Cell Longev. 2021:5826932. PubMed
  254. Zhong W, et al. 2022. Front Immunol. 13:1001255. PubMed
  255. Künzel K, et al. 2022. Heliyon. 8:e10365. PubMed
  256. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  257. Samuel RM, et al. 2020. Cell Stem Cell. 27:876. PubMed
  258. Zhou Q, et al. 2016. Sci Rep. 6:39071. PubMed
  259. Kaabinejadian S, et al. 2016. J Immunol. 196: 4263 - 4273. PubMed
  260. Yu W, et al. 2015. Cell Rep. 12: 610- 21. PubMed
  261. Dong A, et al. 2015. J Biol Chem. 290:8016. PubMed
  262. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account